644 related articles for article (PubMed ID: 34131102)
1. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA OIP5-AS1 serves as a competing endogenous RNA to modulate X-linked inhibitor of apoptosis protein expression via adsorbing miR-429 in papillary thyroid cancer.
Yu CS; Wang YB; Li Q; Yang EL; Dong BB
J Biol Regul Homeost Agents; 2021; 35(3):909-920. PubMed ID: 34155880
[TBL] [Abstract][Full Text] [Related]
3. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
4. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
5. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Liu D; Zhang M; Song Y; Yang N
Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
8. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
Ji L; Fan X; Zhou F; Gu J; Deng X
J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA ABHD11-AS1 functions as a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis.
Zhuang X; Tong H; Ding Y; Wu L; Cai J; Si Y; Zhang H; Shen M
Cell Death Dis; 2019 Aug; 10(8):620. PubMed ID: 31409775
[TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
Hou S; Lin Q; Guan F; Lin C
J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
Chen N; Yin D; Lun B; Guo X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
[TBL] [Abstract][Full Text] [Related]
16. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC00152 promotes cell growth and invasion of papillary thyroid carcinoma by regulating the miR-497/BDNF axis.
Sun Z; Guo X; Zang M; Wang P; Xue S; Chen G
J Cell Physiol; 2019 Feb; 234(2):1336-1345. PubMed ID: 30146756
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis.
Yi D; Zhang D; He J
Cell Cycle; 2021 Dec; 20(24):2619-2637. PubMed ID: 34781815
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]